Moving precision oncology forward
Indivumed (indivumed.com) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 59th percentile of 11249 Healthcare brands.
Indivumed is a precision oncology company founded in 2017 that discovers novel targets for the development of precision cancer therapeutics. It maintains a clinically grounded database built from native tumor biology to accelerate the discovery and validation of cancer targets. The company positions itself as a bridge between clinical tumor data and drug discovery, serving pharmaceutical and biotech companies, oncology researchers, and drug developers who need validated, clinically relevant targets for cancer therapeutics.
| Brand Name | Indivumed |
|---|---|
| Domain | indivumed.com |
| Industry | Healthcare, Technology |
| Founded | 2017 |
| Main Competitors | Tempus Labs (76/100), Foundation Medicine (73/100), Caris Life Sciences (82/100), NeoGenomics (82/100), Champions Oncology (78/100), Strata Oncology |
Moz Domain Authority 37/100 vs category average 41 / leader 97 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,631,931 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "We discover novel targets for the development of precision cancer therapeutics." (Meta description: 11 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Indivumed?", Claude could identify the brand as of October 2026. Indivumed is a German biotech company based in Hamburg that specializes in oncology research, providing high-quality tumor tissue samples and comprehensive molecular and clinical data to support cancer research and drug development. It has built one of the largest standardized bi Best known for Its large, highly standardized biobank of cancer tissue samples paired with molecular and clinical data for oncology drug discovery.
When asked "Best brands similar to Indivumed?", Claude would recommend Indivumed as of October 2026. It's a well-known name in precision oncology and biobanking, so it would naturally come up if discussing companies supporting cancer research with high-quality biospecimens and data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Indivumed's main competitors in Healthcare: Tempus Labs (76/100), Foundation Medicine (73/100), Caris Life Sciences (82/100), NeoGenomics (82/100), Champions Oncology (78/100).
Sources: Brand Analyzer scan
Indivumed has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 19, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Indivumed official site
Indivumed was founded in 2017. Indivumed operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Indivumed scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Indivumed official site
Indivumed is a precision oncology company, founded in 2017, that discovers novel targets for the development of precision cancer therapeutics. It positions itself as a bridge between clinical tumor data and drug discovery, using a clinically grounded database built from native tumor biology to identify cancer targets linked directly to real patient biology.
Sources: Indivumed official site
Indivumed discovers and validates novel targets for precision cancer therapeutics. It captures native tumor biology through a unique, clinically grounded database, which it uses to accelerate the discovery and validation of cancer targets, aiming to move scientific insights from bench to clinic more quickly for pharmaceutical and biotech partners.
Sources: Indivumed official site
Indivumed can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Indivumed official site
Indivumed offers a clinically grounded tumor database and target discovery and validation services for precision cancer therapeutics. These services are designed to help pharmaceutical and biotech companies, oncology researchers, and drug developers identify and validate cancer targets based on native tumor biology and clinically relevant patient data.
Sources: Indivumed official site
Indivumed's services are used by pharmaceutical and biotech companies, oncology researchers, and drug developers who are seeking validated cancer targets and clinically relevant tumor data to support the development of precision cancer therapeutics.
Sources: Indivumed official site
Indivumed is known for its clinically grounded database of native tumor biology, which it uses to discover and validate novel cancer targets. Its positioning emphasizes linking every identified cancer target directly to real patient biology, distinguishing it as a precision oncology company focused on target discovery for drug development.
Sources: Indivumed official site
Indivumed scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Indivumed has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,631,931 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data. In a live check, Claude could already identify Indivumed from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Indivumed: IndieBio (78/100), Indica Labs (78/100), INFORS HT (78/100), Ingles Markets (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.